v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Apr. 30, 2026
Apr. 30, 2025
Income Statement [Abstract]        
Net sales $ 106,004,000 $ 126,787,000 $ 323,797,000 $ 369,161,000
Cost of sales 69,938,000 87,842,000 214,742,000 281,960,000
Gross profit 36,066,000 38,945,000 109,055,000 87,201,000
Expenses:        
Selling, general and administrative 29,331,000 30,203,000 86,950,000 115,679,000
Research and development 5,220,000 4,425,000 13,440,000 12,492,000
Amortization of intangibles 4,597,000 5,044,000 14,684,000 16,680,000
CEO transition costs 40,000 805,000 1,096,000 1,072,000
Proxy solicitation costs 0 0 0 2,682,000
Impairment of long-lived assets, including goodwill 0 0 0 79,555,000
Total operating expenses 39,188,000 40,477,000 116,170,000 228,160,000
Operating loss (3,122,000) (1,532,000) (7,115,000) (140,959,000)
Other expenses (income):        
Interest expense 11,537,000 12,907,000 34,314,000 33,447,000
Interest (income) and other 5,000 (509,000) (426,000) 0
Change in fair value of warrants and derivatives (12,479,000) (49,542,000) (9,763,000) (15,450,000)
Write-off of deferred financing costs and debt discounts 0 3,479,000 0 4,891,000
(Loss) income before provision for (benefit from) income taxes (2,185,000) 32,133,000 (31,240,000) (163,847,000)
Provision for (benefit from) income taxes 1,268,000 (1,801,000) 1,727,000 (635,000)
Net (loss) income (3,453,000) 33,934,000 (32,967,000) (163,212,000)
Establishment of initial convertible preferred stock purchase option liability 0 0 0 (51,179,000)
Dividends on convertible preferred stock, net (10,810,000) (48,405,000) (21,238,000) (80,656,000)
Net loss attributable to common stockholders $ (14,263,000) $ (14,471,000) $ (54,205,000) $ (192,689,000)
Net loss per common share (See Note 5):        
Basic (in dollars per share) $ (0.47) $ (0.49) $ (1.82) $ (6.56)
Diluted (in dollars per share) $ (0.47) $ (0.49) $ (1.82) $ (6.56)
Weighted average number of common shares outstanding - basic (in shares) 30,034,000 29,399,000 29,823,000 29,395,000
Weighted average number of common and common equivalent shares outstanding - diluted (in shares) 30,034,000 29,399,000 29,823,000 29,395,000